LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

LLY

1,031.32

+2.27%↑

JNJ

247.77

+2.27%↑

ABBV

229.86

+2.64%↑

NVS

169.26

+2.47%↑

MRK

123.21

+3.1%↑

Search

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

11.18 2.85

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.58

Max

11.36

Chiffres clés

By Trading Economics

Revenu

479M

-5.4M

Ventes

-14M

402M

Marge bénéficiaire

-1.344

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+12.17% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-340M

916M

Ouverture précédente

8.33

Clôture précédente

11.18

Sentiment de l'Actualité

By Acuity

50%

50%

168 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 févr. 2026, 22:04 UTC

Résultats

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26 févr. 2026, 23:55 UTC

Market Talk

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26 févr. 2026, 23:40 UTC

Acquisitions, Fusions, Rachats

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26 févr. 2026, 23:37 UTC

Market Talk

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26 févr. 2026, 23:32 UTC

Résultats

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26 févr. 2026, 23:19 UTC

Acquisitions, Fusions, Rachats

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 févr. 2026, 23:18 UTC

Acquisitions, Fusions, Rachats

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26 févr. 2026, 23:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

26 févr. 2026, 23:12 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26 févr. 2026, 23:01 UTC

Acquisitions, Fusions, Rachats

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 févr. 2026, 23:00 UTC

Acquisitions, Fusions, Rachats

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 févr. 2026, 23:00 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 févr. 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26 févr. 2026, 22:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26 févr. 2026, 22:43 UTC

Market Talk

RBA Hike In March Is Being Underpriced -- Market Talk

26 févr. 2026, 22:33 UTC

Acquisitions, Fusions, Rachats

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 févr. 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26 févr. 2026, 22:13 UTC

Market Talk
Acquisitions, Fusions, Rachats

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26 févr. 2026, 21:59 UTC

Résultats

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26 févr. 2026, 21:58 UTC

Acquisitions, Fusions, Rachats

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26 févr. 2026, 21:49 UTC

Résultats

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26 févr. 2026, 21:45 UTC

Résultats

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26 févr. 2026, 21:44 UTC

Résultats

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26 févr. 2026, 21:44 UTC

Résultats

Coles Expects Market to Remain Highly Competitive

26 févr. 2026, 21:44 UTC

Résultats

Coles Says Supermarket Customers Remain Value Oriented

26 févr. 2026, 21:43 UTC

Résultats

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26 févr. 2026, 21:43 UTC

Résultats

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26 févr. 2026, 21:42 UTC

Acquisitions, Fusions, Rachats

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26 févr. 2026, 21:41 UTC

Résultats
Acquisitions, Fusions, Rachats

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

12.17% hausse

Prévisions sur 12 Mois

Moyen 13 USD  12.17%

Haut 13 USD

Bas 13 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

168 / 352Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat